Source: Eur Respir J, 57 (4) 2002485; 10.1183/13993003.02485-2020
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Fabien Maldonado, Cyril Varghese, Srinivasan Rajagopalan, Fenghai Duan, Aneri B. Balar, Dhairya A. Lakhani, Sanja L. Antic, Pierre P. Massion, Tucker F. Johnson, Ronald A. Karwoski, Richard A. Robb, Brian J. Bartholmai, Tobias Peikert. Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. Eur Respir J, 57 (4) 2002485; 10.1183/13993003.02485-2020

Member's Comments

No comment yet.

Related content which might interest you: Validation of lung nodule detection a year before diagnosis in NLST dataset based on a deep learning system Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Probability of malignancy based on automatic segmentation and software measurements of nodules in the Danish lung cancer screening trial (DLCST) Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Radiological features of solitary pulmonary nodule (SPN) and application of two lung cancer prediction models Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Diagnostic accuracy of St. Luke’s – Lung Cancer Risk Prediction Scoring (SL - CaRPS), a novel tool in predicting malignancy among adult patients with CT – scan diagnosed pulmonary nodules Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Validation of CALIPER (Computer-aided lung informatics for pathology evaluation and rating) for the non-invasive assessment of pulmonary nodules of the adenocarcinoma spectrum Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Validation of a risk stratification model for patients with isolated mediastinal/hilar lymphadenopathy (IMHL) and a negative EBUS Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Tumor marker assessment in cytologically negative pleural effusions from lung cancer by Machine Learning-based approach Source: International Congress 2018 – General thoracic surgery Year: 2018 Prognostic value of modified classification based on lung function tests in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Ηypoechogenicity Ιndex (HI) as a novel, pleural effusions’ grayscale sonographic parameter and its correlation with fluid’s analysis results Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Microarray and protein biomarker analysis of endobronchial epithelial lining fluid (EELF) in the evaluation of indeterminate pulmonary nodules (IPN) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 EBUS vs EUS-B for diagnosing sarcoidosis:the International Sarcoidosis Assessment (ISA) RCT Source: International Congress 2018 – EUS-B and EBUS: optimal utilisation of the EBUS scope Year: 2018 Validation of existing clinical prediction models for patients with solitary pulmonary nodules (SPN) managed by a lung multi-disciplinary team (MDT) Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Profile and nodule characteristics of patients with incidental subsolid pulmonary nodules (SSN) Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 The accuracy of FEF25-75/FVC for primary classification of pulmonary function test Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010 Evaluation of the clinical utility of EBUS-TBNA sampling with ROSE (Rapid On-Site Evaluation) in the diagnosis of mediastinal and hilar metastatic non-lung extrathoracic primary carcinoma Source: Virtual Congress 2021 – Convex probe endobronchial ultrasound and radial probe endobronchial ultrasound Year: 2021 Comparison of 3 prediction scores for diagnosis of Pulmonary Embolism Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 3D-simulation in an integrated assessment of the dynamics in patients with disseminated pulmonary lesions (DPL) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Development of a malignancy predicting score in EBUS-TBNA Source: International Congress 2019 – Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration Year: 2019